4
Changes in Ownership
VERACYTE, INC. Filed Acc 0001649245-26-000009
Chief Scientific & Med Officer sold 13,110 shares at an average $43.05 ($564,410)
- Chief Scientific & Med Officer gave up 3,639 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Febbo Phillip G. Chief Scientific & Med Officer | 2026-09-02 | Shares withheld for taxes 10b5-1 | −3,639 | $44.88 | $163,318 | 146,158 | D: show line 1 in the form |
| Febbo Phillip G. Chief Scientific & Med Officer | 2026-09-04 | Sale 10b5-1 | −10,405 | $42.89 | $446,305 | 135,753 | D: show line 2 in the form |
| Febbo Phillip G. Chief Scientific & Med Officer | 2026-09-04 | Sale 10b5-1 | −2,705 | $43.66 | $118,105 | 133,048 | D: show line 3 in the form |
| Open-market sales · 13,110 sh · avg $43.05 · $564,410 | |||||||
Loading xslF345X06/wk-form4_1788566051.xml…